Full Year 2019 Valneva SE Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Valneva presents its full year 2019 results. (Operator Instructions) Also I must advise that the call is being recorded today, Thursday, the 27th of February 2020.
And without any further delay, I would now like to hand over the call to your first speaker today, Thomas Lingelbach, CEO of Valneva. Thank you. Please go ahead.
Thank you so much. Good day, and very warm welcome to all of you to our call today where we're going to present our full year 2019 financial results as well as provide you with some business updates.
Well, I mean 2019 has been an exceptional year for Valneva. We have achieved our highest sales revenues ever from our 2 commercial travelers vaccines against Japanese encephalitis and cholera, and we have been able to make great progress on our 2 unique R&D programs.
If we look at Slide 4 of the presentation, we basically gained full control of R&D assets
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |